Skip to content

The Lolland-Falster Health Study

The Lolland-Falster Health Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02482896
Acronym
LOFUS
Enrollment
25000
Registered
2015-06-26
Start date
2016-02-29
Completion date
2019-12-31
Last updated
2016-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis, Chronic Disease, Coronary Disease, Disease, Ear Diseases, Impaired Health, Mental Disorders, Nose Diseases, Personality, Pharyngeal Diseases, Renal Insufficiency, Chronic, Skin Diseases, Urinary Incontinence, Wellbeing

Brief summary

The study is a epidemiological, cross-sectional study in a mainly rural area of Denmark in Denmark. Life expectancy is shorter, morbidity is higher, and social problems more prevalent than in the urban areas of the country. The population study aims at examining complexities of environmental, hereditary, lifestyle, and social factors as determinants and predisposing factors for morbidity, health, and quality of life. The study will cover physical, mental, and social dimensions and examine family patterns and subgroups. The study will provide baseline information for later follow-up.

Interventions

None listed

Sponsors

Lolland Municipality, Denmark
CollaboratorUNKNOWN
Guldborgsund Municipality, Denmark
CollaboratorUNKNOWN
Region Sjælland
Lead SponsorOTHER

Study design

Observational model
FAMILY_BASED
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
No minimum to 110 Years
Healthy volunteers
No

Inclusion criteria

* Individuals registered in Lolland or Guldborgsund municipality

Exclusion criteria

* Adults with incapacity guardianship * Incapacity to give informed consent * Individuals with address protection * Severe physical immobility * Non-Danish and Non-English speaking

Design outcomes

Primary

MeasureTime frameDescription
HealthCross-sectional, measured onceSelf-administered questionnaires, clinical examination, and biospecimen

Secondary

MeasureTime frameDescription
MorbidityCross-sectional, measured onceSelf-administered questionnaires, clinical examination, and biospecimen
Risk factorsCross-sectional, measured onceSelf-administered questionnaires, clinical examination, and biospecimen

Countries

Denmark

Contacts

Primary ContactRandi Jepsen, PhD, MSc, RN
rjep@regionsjaelland.dk+4556516856

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026